The global medical equipment and diagnostic equipment market was valued at USD 439.3 billion in 2024 and is projected to grow to USD 696.4 billion by 2030, with a CAGR of 8.1% over the forecast period from 2024 to 2030. The increase in autoimmune disorders, such as arthritis and multiple sclerosis, is one of the major factors driving market growth, as this situation tends to increase demand for advanced treatment monitoring systems. Furthermore, growing momentum in personalized medicine and the application of blockchain in managing health records open prospects for data-driven patient care.
Table of Contents
1. Introduction
1.1. Study Objective
1.2. Scope of the report
1.3. Market Taxonomy
1.4. Study Assumptions and Abbreviations
1.2. Scope of the report
1.3. Market Taxonomy
1.4. Study Assumptions and Abbreviations
2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. SPSS Approach
2.4. Data Triangulation
2.2. Primary Research
2.3. SPSS Approach
2.4. Data Triangulation
4. Global Industry Overview
4.1. Market Overview
4.2. Regional Synopsis
4.3. Industry Supply Chain Analysis
4.4. DROT
4.5. Government Regulation
4.6. Competitive Landscape
4.6.1. Johnson & Johnson
4.6.2. Medtronic
4.6.3. GE Healthcare
4.6.4. Siemens Healthcare Private Limited
4.6.5. Koninklijke Philips N.V.
4.6.6. Boston Scientific Corporation
4.6.7. Becton Dickinson and Company
4.6.8. Siemens Healthineers AG
4.6.9. ZIMMER BIOMET HOLDINGS, INC.
4.6.10. Stryker Corporation
4.7. Ongoing Technological Advancements
4.8. Price Benchmarking
4.9. SWOT Analysis
4.10. Patent Analysis
4.11. Future Trends
4.12. End User Analysis
4.13. Analysis of Innovative Advancements by Key Players
4.14. Raw Materials for Medical and Diagnostic Equipment
4.15. Resins Used in Medical and Diagnostic Equipment
4.16. Volume of Each Engineering Plastics Used for Each Drug Delivery System
4.17. Volume of Each Engineering Plastics Used for Each Medical Devices
4.18. Volume of Each Engineering Plastics Used for Each Diagnostics Devices
4.19. Major Manufacturers for Each Medical/Diagnostic Device
4.20. Root Cause Analysis
4.21. Porter’s Five Forces
4.22. Production Value and Volume of Equipment
4.23. Strategic Initiatives Adopted by Key Players
4.24. Company Share in the Market
4.2. Regional Synopsis
4.3. Industry Supply Chain Analysis
4.4. DROT
4.5. Government Regulation
4.6. Competitive Landscape
4.6.1. Johnson & Johnson
4.6.2. Medtronic
4.6.3. GE Healthcare
4.6.4. Siemens Healthcare Private Limited
4.6.5. Koninklijke Philips N.V.
4.6.6. Boston Scientific Corporation
4.6.7. Becton Dickinson and Company
4.6.8. Siemens Healthineers AG
4.6.9. ZIMMER BIOMET HOLDINGS, INC.
4.6.10. Stryker Corporation
4.7. Ongoing Technological Advancements
4.8. Price Benchmarking
4.9. SWOT Analysis
4.10. Patent Analysis
4.11. Future Trends
4.12. End User Analysis
4.13. Analysis of Innovative Advancements by Key Players
4.14. Raw Materials for Medical and Diagnostic Equipment
4.15. Resins Used in Medical and Diagnostic Equipment
4.16. Volume of Each Engineering Plastics Used for Each Drug Delivery System
4.17. Volume of Each Engineering Plastics Used for Each Medical Devices
4.18. Volume of Each Engineering Plastics Used for Each Diagnostics Devices
4.19. Major Manufacturers for Each Medical/Diagnostic Device
4.20. Root Cause Analysis
4.21. Porter’s Five Forces
4.22. Production Value and Volume of Equipment
4.23. Strategic Initiatives Adopted by Key Players
4.24. Company Share in the Market
5. Global Outlook and Projections
5.1. Global Overview
5.2. Market Value (USD Billion), Volume (Thousand Units), Current and Future Projections, 2024-2030
5.3. Increment $ Opportunity Assessment, 2024-2030
5.4. Year-on-Year Growth Forecast (%)
5.5. Segmentation (USD Billion), 2024-2030, By
5.5.1. Product Type, Value (USD Billion), Volume (Thousand Units)
5.5.1.1. Drug Delivery Systems
5.5.1.1.1. Inhalers
5.5.1.1.2. Nebulizers
5.5.1.1.3. Insulin Pumps
5.5.1.1.4. Chemotherapy Pumps
5.5.1.1.5. Pain Management Pumps
5.5.1.1.6. Pen Injectors
5.5.1.1.7. Syringes
5.5.1.1.8. Auto-Injectors
5.5.1.1.9. Transdermal Patches
5.5.1.1.10. Others
5.5.1.2. Medical Devices
5.5.1.2.1. Pacemakers
5.5.1.2.2. Cochlear Implants
5.5.1.2.3. Orthopedic Implants
5.5.1.2.4. Glucose Monitors
5.5.1.2.5. Pluse Oximeters
5.5.1.2.6. Blood Pressure Monitors
5.5.1.2.7. Dialysis Machines
5.5.1.2.8. Respirators
5.5.1.2.9. Endoscopes
5.5.1.2.9.1. Single Use
5.5.1.2.9.2. Reusable
5.5.1.2.10. Laparoscopic Instruments
5.5.1.2.11. Catheters
5.5.1.2.12. Scalpels
5.5.1.2.13. Forceps
5.5.1.2.14. Retractors
5.5.1.2.15. Surgical Sutures
5.5.1.2.16. Others
5.5.1.3. Diagnostic Devices
5.5.1.3.1. X-ray Machines
5.5.1.3.2. MRI Scanners
5.5.1.3.3. CT Scanners
5.5.1.3.4. Ultrasound Systems
5.5.1.3.5. Rapid HIV Tests
5.5.1.3.6. Blood Gas Analyzers
5.5.1.3.7. PCR Machines
5.5.1.3.8. Immunoassay Analyzers
5.5.1.3.9. Hematology Analyzers
5.5.1.3.10. DNA Sequencers
5.5.1.3.11. Ophthalmoscopes
5.5.1.3.12. ECG Monitors
5.5.1.3.13. Holter Monitors
5.5.1.3.14. Smartwatches with Health Monitoring Features
5.5.1.3.15. Others
5.5.2. Raw Material, Value (USD Billion)
5.5.2.1. Metal
5.5.2.2. Plastic
5.5.2.2.1. General-Purpose Engineering Plastics
5.5.2.2.2. Super Engineering Plastics
5.5.2.3. Ceramics
5.5.2.4. Others
5.5.3. End User, Value (USD Billion)
5.5.3.1. Hospitals
5.5.3.2. Clinics
5.5.3.3. Diagnostic Centers
5.5.3.4. Ambulatory Surgical Centers (ASCs)
5.5.3.5. Research Laboratories
5.5.3.6. Home Healthcare
5.5.4. Regional Synopsis (USD Billion), 2024-2030
5.5.4.1. North America, Value (USD Billion), Volume (Thousand Units)
5.5.4.2. Europe, Value (USD Billion), Volume (Thousand Units)
5.5.4.3. Asia Pacific, Value (USD Billion), Volume (Thousand Units)
5.5.4.4. Latin America, Value (USD Billion), Volume (Thousand Units)
5.5.4.5. Middle East and Africa, Value (USD Billion), Volume (Thousand Units)
5.2. Market Value (USD Billion), Volume (Thousand Units), Current and Future Projections, 2024-2030
5.3. Increment $ Opportunity Assessment, 2024-2030
5.4. Year-on-Year Growth Forecast (%)
5.5. Segmentation (USD Billion), 2024-2030, By
5.5.1. Product Type, Value (USD Billion), Volume (Thousand Units)
5.5.1.1. Drug Delivery Systems
5.5.1.1.1. Inhalers
5.5.1.1.2. Nebulizers
5.5.1.1.3. Insulin Pumps
5.5.1.1.4. Chemotherapy Pumps
5.5.1.1.5. Pain Management Pumps
5.5.1.1.6. Pen Injectors
5.5.1.1.7. Syringes
5.5.1.1.8. Auto-Injectors
5.5.1.1.9. Transdermal Patches
5.5.1.1.10. Others
5.5.1.2. Medical Devices
5.5.1.2.1. Pacemakers
5.5.1.2.2. Cochlear Implants
5.5.1.2.3. Orthopedic Implants
5.5.1.2.4. Glucose Monitors
5.5.1.2.5. Pluse Oximeters
5.5.1.2.6. Blood Pressure Monitors
5.5.1.2.7. Dialysis Machines
5.5.1.2.8. Respirators
5.5.1.2.9. Endoscopes
5.5.1.2.9.1. Single Use
5.5.1.2.9.2. Reusable
5.5.1.2.10. Laparoscopic Instruments
5.5.1.2.11. Catheters
5.5.1.2.12. Scalpels
5.5.1.2.13. Forceps
5.5.1.2.14. Retractors
5.5.1.2.15. Surgical Sutures
5.5.1.2.16. Others
5.5.1.3. Diagnostic Devices
5.5.1.3.1. X-ray Machines
5.5.1.3.2. MRI Scanners
5.5.1.3.3. CT Scanners
5.5.1.3.4. Ultrasound Systems
5.5.1.3.5. Rapid HIV Tests
5.5.1.3.6. Blood Gas Analyzers
5.5.1.3.7. PCR Machines
5.5.1.3.8. Immunoassay Analyzers
5.5.1.3.9. Hematology Analyzers
5.5.1.3.10. DNA Sequencers
5.5.1.3.11. Ophthalmoscopes
5.5.1.3.12. ECG Monitors
5.5.1.3.13. Holter Monitors
5.5.1.3.14. Smartwatches with Health Monitoring Features
5.5.1.3.15. Others
5.5.2. Raw Material, Value (USD Billion)
5.5.2.1. Metal
5.5.2.2. Plastic
5.5.2.2.1. General-Purpose Engineering Plastics
5.5.2.2.2. Super Engineering Plastics
5.5.2.3. Ceramics
5.5.2.4. Others
5.5.3. End User, Value (USD Billion)
5.5.3.1. Hospitals
5.5.3.2. Clinics
5.5.3.3. Diagnostic Centers
5.5.3.4. Ambulatory Surgical Centers (ASCs)
5.5.3.5. Research Laboratories
5.5.3.6. Home Healthcare
5.5.4. Regional Synopsis (USD Billion), 2024-2030
5.5.4.1. North America, Value (USD Billion), Volume (Thousand Units)
5.5.4.2. Europe, Value (USD Billion), Volume (Thousand Units)
5.5.4.3. Asia Pacific, Value (USD Billion), Volume (Thousand Units)
5.5.4.4. Latin America, Value (USD Billion), Volume (Thousand Units)
5.5.4.5. Middle East and Africa, Value (USD Billion), Volume (Thousand Units)
6. North America Market
6.1. Overview
6.1.1. Market Value (USD Billion), Volume (Thousand Units), Current and Future Projections, 2024-2030
6.1.2. Increment $ Opportunity Assessment, 2024-2030
6.1.3. Year-on-Year Growth Forecast (%)
6.1.4. Segmentation (USD Billion), 2024-2030, By
6.1.4.1. Product Type, Value (USD Billion), Volume (Thousand Units)
6.1.4.1.1. Drug Delivery Systems
6.1.4.1.1.1. Inhalers
6.1.4.1.1.2. Nebulizers
6.1.4.1.1.3. Insulin Pumps
6.1.4.1.1.4. Chemotherapy Pumps
6.1.4.1.1.5. Pain Management Pumps
6.1.4.1.1.6. Pen Injectors
6.1.4.1.1.7. Syringes
6.1.4.1.1.8. Auto-Injectors
6.1.4.1.1.9. Transdermal Patches
6.1.4.1.1.10. Others
6.1.4.1.2. Medical Devices
6.1.4.1.2.1. Pacemakers
6.1.4.1.2.2. Cochlear Implants
6.1.4.1.2.3. Orthopedic Implants
6.1.4.1.2.4. Glucose Monitors
6.1.4.1.2.5. Pluse Oximeters
6.1.4.1.2.6. Blood Pressure Monitors
6.1.4.1.2.7. Dialysis Machines
6.1.4.1.2.8. Respirators
6.1.4.1.2.9. Endoscopes
6.1.4.1.2.9.1. Single Use
6.1.4.1.2.9.2. Reusable
6.1.4.1.2.10. Laparoscopic Instruments
6.1.4.1.2.11. Catheters
6.1.4.1.2.12. Scalpels
6.1.4.1.2.13. Forceps
6.1.4.1.2.14. Retractors
6.1.4.1.2.15. Surgical Sutures
6.1.4.1.2.16. Others
6.1.4.1.3. Diagnostic Devices
6.1.4.1.3.1. X-ray Machines
6.1.4.1.3.2. MRI Scanners
6.1.4.1.3.3. CT Scanners
6.1.4.1.3.4. Ultrasound Systems
6.1.4.1.3.5. Blood Glucose Meters
6.1.4.1.3.6. Rapid HIV Tests
6.1.4.1.3.7. Blood Gas Analyzers
6.1.4.1.3.8. PCR Machines
6.1.4.1.3.9. Immunoassay Analyzers
6.1.4.1.3.10. Hematology Analyzers
6.1.4.1.3.11. DNA Sequencers
6.1.4.1.3.12. Ophthalmoscopes
6.1.4.1.3.13. ECG Monitors
6.1.4.1.3.14. Holter Monitors
6.1.4.1.3.15. Smartwatches with Health Monitoring Features
6.1.4.1.3.16. Others
6.1.4.2. Raw Material, Value (USD Billion)
6.1.4.2.1. Metal
6.1.4.2.2. Plastic
6.1.4.2.2.1. General-Purpose Engineering Plastics
6.1.4.2.2.2. Super Engineering Plastics
6.1.4.2.3. Ceramics
6.1.4.2.4. Others
6.1.4.3. End User, Value (USD Billion)
6.1.4.3.1. Hospitals
6.1.4.3.2. Clinics
6.1.4.3.3. Diagnostic Centers
6.1.4.3.3.1.1. Ambulatory Surgical Centers (ASCs)
6.1.4.3.3.1.2. Research Laboratories
6.1.4.3.3.1.3. Home Healthcare
6.1.4.4. Country Level Analysis
6.1.4.4.1. US
6.1.4.4.2. Canada
6.1.1. Market Value (USD Billion), Volume (Thousand Units), Current and Future Projections, 2024-2030
6.1.2. Increment $ Opportunity Assessment, 2024-2030
6.1.3. Year-on-Year Growth Forecast (%)
6.1.4. Segmentation (USD Billion), 2024-2030, By
6.1.4.1. Product Type, Value (USD Billion), Volume (Thousand Units)
6.1.4.1.1. Drug Delivery Systems
6.1.4.1.1.1. Inhalers
6.1.4.1.1.2. Nebulizers
6.1.4.1.1.3. Insulin Pumps
6.1.4.1.1.4. Chemotherapy Pumps
6.1.4.1.1.5. Pain Management Pumps
6.1.4.1.1.6. Pen Injectors
6.1.4.1.1.7. Syringes
6.1.4.1.1.8. Auto-Injectors
6.1.4.1.1.9. Transdermal Patches
6.1.4.1.1.10. Others
6.1.4.1.2. Medical Devices
6.1.4.1.2.1. Pacemakers
6.1.4.1.2.2. Cochlear Implants
6.1.4.1.2.3. Orthopedic Implants
6.1.4.1.2.4. Glucose Monitors
6.1.4.1.2.5. Pluse Oximeters
6.1.4.1.2.6. Blood Pressure Monitors
6.1.4.1.2.7. Dialysis Machines
6.1.4.1.2.8. Respirators
6.1.4.1.2.9. Endoscopes
6.1.4.1.2.9.1. Single Use
6.1.4.1.2.9.2. Reusable
6.1.4.1.2.10. Laparoscopic Instruments
6.1.4.1.2.11. Catheters
6.1.4.1.2.12. Scalpels
6.1.4.1.2.13. Forceps
6.1.4.1.2.14. Retractors
6.1.4.1.2.15. Surgical Sutures
6.1.4.1.2.16. Others
6.1.4.1.3. Diagnostic Devices
6.1.4.1.3.1. X-ray Machines
6.1.4.1.3.2. MRI Scanners
6.1.4.1.3.3. CT Scanners
6.1.4.1.3.4. Ultrasound Systems
6.1.4.1.3.5. Blood Glucose Meters
6.1.4.1.3.6. Rapid HIV Tests
6.1.4.1.3.7. Blood Gas Analyzers
6.1.4.1.3.8. PCR Machines
6.1.4.1.3.9. Immunoassay Analyzers
6.1.4.1.3.10. Hematology Analyzers
6.1.4.1.3.11. DNA Sequencers
6.1.4.1.3.12. Ophthalmoscopes
6.1.4.1.3.13. ECG Monitors
6.1.4.1.3.14. Holter Monitors
6.1.4.1.3.15. Smartwatches with Health Monitoring Features
6.1.4.1.3.16. Others
6.1.4.2. Raw Material, Value (USD Billion)
6.1.4.2.1. Metal
6.1.4.2.2. Plastic
6.1.4.2.2.1. General-Purpose Engineering Plastics
6.1.4.2.2.2. Super Engineering Plastics
6.1.4.2.3. Ceramics
6.1.4.2.4. Others
6.1.4.3. End User, Value (USD Billion)
6.1.4.3.1. Hospitals
6.1.4.3.2. Clinics
6.1.4.3.3. Diagnostic Centers
6.1.4.3.3.1.1. Ambulatory Surgical Centers (ASCs)
6.1.4.3.3.1.2. Research Laboratories
6.1.4.3.3.1.3. Home Healthcare
6.1.4.4. Country Level Analysis
6.1.4.4.1. US
6.1.4.4.2. Canada
7. Europe Market
7.1. Overview
7.1.1. Market Value (USD Billion), Volume (Thousand Units), Current and Future Projections, 2024-2030
7.1.2. Increment $ Opportunity Assessment, 2024-2030
7.1.3. Year-on-Year Growth Forecast (%)
7.1.4. Segmentation (USD Billion), 2024-2030, By
7.1.4.1. Product Type, Value (USD Billion), Volume (Thousand Units)
7.1.4.1.1. Drug Delivery Systems
7.1.4.1.1.1. Inhalers
7.1.4.1.1.2. Nebulizers
7.1.4.1.1.3. Insulin Pumps
7.1.4.1.1.4. Chemotherapy Pumps
7.1.4.1.1.5. Pain Management Pumps
7.1.4.1.1.6. Pen Injectors
7.1.4.1.1.7. Syringes
7.1.4.1.1.8. Auto-Injectors
7.1.4.1.1.9. Transdermal Patches
7.1.4.1.1.10. Others
7.1.4.1.2. Medical Devices
7.1.4.1.2.1. Pacemakers
7.1.4.1.2.2. Cochlear Implants
7.1.4.1.2.3. Orthopedic Implants
7.1.4.1.2.4. Glucose Monitors
7.1.4.1.2.5. Pluse Oximeters
7.1.4.1.2.6. Blood Pressure Monitors
7.1.4.1.2.7. Dialysis Machines
7.1.4.1.2.8. Respirators
7.1.4.1.2.9. Endoscopes
7.1.4.1.2.9.1. Single Use
7.1.4.1.2.9.2. Reusable
7.1.4.1.2.10. Laparoscopic Instruments
7.1.4.1.2.11. Catheters
7.1.4.1.2.12. Scalpels
7.1.4.1.2.13. Forceps
7.1.4.1.2.14. Retractors
7.1.4.1.2.15. Surgical Sutures
7.1.4.1.2.16. Others
7.1.4.1.3. Diagnostic Devices
7.1.4.1.3.1. X-ray Machines
7.1.4.1.3.2. MRI Scanners
7.1.4.1.3.3. CT Scanners
7.1.4.1.3.4. Ultrasound Systems
7.1.4.1.3.5. Blood Glucose Meters
7.1.4.1.3.6. Rapid HIV Tests
7.1.4.1.3.7. Blood Gas Analyzers
7.1.4.1.3.8. PCR Machines
7.1.4.1.3.9. Immunoassay Analyzers
7.1.4.1.3.10. Hematology Analyzers
7.1.4.1.3.11. DNA Sequencers
7.1.4.1.3.12. Ophthalmoscopes
7.1.4.1.3.13. ECG Monitors
7.1.4.1.3.14. Holter Monitors
7.1.4.1.3.15. Smartwatches with Health Monitoring Features
7.1.4.1.3.16. Others
7.1.4.2. Raw Material, Value (USD Billion)
7.1.4.2.1. Metal
7.1.4.2.2. Plastic
7.1.4.2.2.1. General-Purpose Engineering Plastics
7.1.4.2.2.2. Super Engineering Plastics
7.1.4.2.3. Ceramics
7.1.4.2.4. Others
7.1.4.3. End User, Value (USD Billion)
7.1.4.3.1. Hospitals
7.1.4.3.2. Clinics
7.1.4.3.3. Diagnostic Centers
7.1.4.3.4. Ambulatory Surgical Centers (ASCs)
7.1.4.3.5. Research Laboratories
7.1.4.3.6. Home Healthcare
7.1.4.4. Country Level Analysis
7.1.4.4.1. UK
7.1.4.4.2. Germany
7.1.4.4.3. France
7.1.4.4.4. Italy
7.1.4.4.5. Spain
7.1.4.4.6. NORDIC
7.1.4.4.7. Russia
7.1.4.4.8. Rest of Europe
7.1.1. Market Value (USD Billion), Volume (Thousand Units), Current and Future Projections, 2024-2030
7.1.2. Increment $ Opportunity Assessment, 2024-2030
7.1.3. Year-on-Year Growth Forecast (%)
7.1.4. Segmentation (USD Billion), 2024-2030, By
7.1.4.1. Product Type, Value (USD Billion), Volume (Thousand Units)
7.1.4.1.1. Drug Delivery Systems
7.1.4.1.1.1. Inhalers
7.1.4.1.1.2. Nebulizers
7.1.4.1.1.3. Insulin Pumps
7.1.4.1.1.4. Chemotherapy Pumps
7.1.4.1.1.5. Pain Management Pumps
7.1.4.1.1.6. Pen Injectors
7.1.4.1.1.7. Syringes
7.1.4.1.1.8. Auto-Injectors
7.1.4.1.1.9. Transdermal Patches
7.1.4.1.1.10. Others
7.1.4.1.2. Medical Devices
7.1.4.1.2.1. Pacemakers
7.1.4.1.2.2. Cochlear Implants
7.1.4.1.2.3. Orthopedic Implants
7.1.4.1.2.4. Glucose Monitors
7.1.4.1.2.5. Pluse Oximeters
7.1.4.1.2.6. Blood Pressure Monitors
7.1.4.1.2.7. Dialysis Machines
7.1.4.1.2.8. Respirators
7.1.4.1.2.9. Endoscopes
7.1.4.1.2.9.1. Single Use
7.1.4.1.2.9.2. Reusable
7.1.4.1.2.10. Laparoscopic Instruments
7.1.4.1.2.11. Catheters
7.1.4.1.2.12. Scalpels
7.1.4.1.2.13. Forceps
7.1.4.1.2.14. Retractors
7.1.4.1.2.15. Surgical Sutures
7.1.4.1.2.16. Others
7.1.4.1.3. Diagnostic Devices
7.1.4.1.3.1. X-ray Machines
7.1.4.1.3.2. MRI Scanners
7.1.4.1.3.3. CT Scanners
7.1.4.1.3.4. Ultrasound Systems
7.1.4.1.3.5. Blood Glucose Meters
7.1.4.1.3.6. Rapid HIV Tests
7.1.4.1.3.7. Blood Gas Analyzers
7.1.4.1.3.8. PCR Machines
7.1.4.1.3.9. Immunoassay Analyzers
7.1.4.1.3.10. Hematology Analyzers
7.1.4.1.3.11. DNA Sequencers
7.1.4.1.3.12. Ophthalmoscopes
7.1.4.1.3.13. ECG Monitors
7.1.4.1.3.14. Holter Monitors
7.1.4.1.3.15. Smartwatches with Health Monitoring Features
7.1.4.1.3.16. Others
7.1.4.2. Raw Material, Value (USD Billion)
7.1.4.2.1. Metal
7.1.4.2.2. Plastic
7.1.4.2.2.1. General-Purpose Engineering Plastics
7.1.4.2.2.2. Super Engineering Plastics
7.1.4.2.3. Ceramics
7.1.4.2.4. Others
7.1.4.3. End User, Value (USD Billion)
7.1.4.3.1. Hospitals
7.1.4.3.2. Clinics
7.1.4.3.3. Diagnostic Centers
7.1.4.3.4. Ambulatory Surgical Centers (ASCs)
7.1.4.3.5. Research Laboratories
7.1.4.3.6. Home Healthcare
7.1.4.4. Country Level Analysis
7.1.4.4.1. UK
7.1.4.4.2. Germany
7.1.4.4.3. France
7.1.4.4.4. Italy
7.1.4.4.5. Spain
7.1.4.4.6. NORDIC
7.1.4.4.7. Russia
7.1.4.4.8. Rest of Europe
8. Asia Pacific Market
8.1. Overview
8.1.1. Market Value (USD Billion), Volume (Thousand Units), Current and Future Projections, 2024-2030
8.1.2. Increment $ Opportunity Assessment, 2024-2030
8.1.3. Year-on-Year Growth Forecast (%)
8.1.4. Segmentation (USD Billion), 2024-2030, By
8.1.4.1. Product Type, Value (USD Billion), Volume (Thousand Units)
8.1.4.1.1. Drug Delivery Systems
8.1.4.1.1.1. Inhalers
8.1.4.1.1.2. Nebulizers
8.1.4.1.1.3. Insulin Pumps
8.1.4.1.1.4. Chemotherapy Pumps
8.1.4.1.1.5. Pain Management Pumps
8.1.4.1.1.6. Pen Injectors
8.1.4.1.1.7. Syringes
8.1.4.1.1.8. Auto-Injectors
8.1.4.1.1.9. Transdermal Patches
8.1.4.1.1.10. Others
8.1.4.1.2. Medical Devices
8.1.4.1.2.1. Pacemakers
8.1.4.1.2.2. Cochlear Implants
8.1.4.1.2.3. Orthopedic Implants
8.1.4.1.2.4. Glucose Monitors
8.1.4.1.2.5. Pluse Oximeters
8.1.4.1.2.6. Blood Pressure Monitors
8.1.4.1.2.7. Dialysis Machines
8.1.4.1.2.8. Respirators
8.1.4.1.2.9. Endoscopes
8.1.4.1.2.9.1. Single Use
8.1.4.1.2.9.2. Reusable
8.1.4.1.2.10. Laparoscopic Instruments
8.1.4.1.2.11. Catheters
8.1.4.1.2.12. Scalpels
8.1.4.1.2.13. Forceps
8.1.4.1.2.14. Retractors
8.1.4.1.2.15. Surgical Sutures
8.1.4.1.2.16. Others
8.1.4.1.3. Diagnostic Devices
8.1.4.1.3.1. X-ray Machines
8.1.4.1.3.2. MRI Scanners
8.1.4.1.3.3. CT Scanners
8.1.4.1.3.4. Ultrasound Systems
8.1.4.1.3.5. Blood Glucose Meters
8.1.4.1.3.6. Rapid HIV Tests
8.1.4.1.3.7. Blood Gas Analyzers
8.1.4.1.3.8. PCR Machines
8.1.4.1.3.9. Immunoassay Analyzers
8.1.4.1.3.10. Hematology Analyzers
8.1.4.1.3.11. DNA Sequencers
8.1.4.1.3.12. Ophthalmoscopes
8.1.4.1.3.13. ECG Monitors
8.1.4.1.3.14. Holter Monitors
8.1.4.1.3.15. Smartwatches with Health Monitoring Features
8.1.4.1.3.16. Others
8.1.4.2. Raw Material, Value (USD Billion)
8.1.4.2.1. Metal
8.1.4.2.2. Plastic
8.1.4.2.2.1. General-Purpose Engineering Plastics
8.1.4.2.2.2. Super Engineering Plastics
8.1.4.2.3. Ceramics
8.1.4.2.4. Others
8.1.4.3. End User, Value (USD Billion)
8.1.4.3.1. Hospitals
8.1.4.3.2. Clinics
8.1.4.3.3. Diagnostic Centers
8.1.4.3.4. Ambulatory Surgical Centers (ASCs)
8.1.4.3.5. Research Laboratories
8.1.4.3.6. Home Healthcare
8.1.4.4. Country Level Analysis
8.1.4.4.1. China
8.1.4.4.2. Japan
8.1.4.4.3. India
8.1.4.4.4. Australia
8.1.4.4.5. South Korea
8.1.4.4.6. Vietnam
8.1.4.4.7. Thailand
8.1.4.4.8. Singapore
8.1.4.4.9. Malaysia
8.1.4.4.10. Rest of Asia Pacific
8.1.1. Market Value (USD Billion), Volume (Thousand Units), Current and Future Projections, 2024-2030
8.1.2. Increment $ Opportunity Assessment, 2024-2030
8.1.3. Year-on-Year Growth Forecast (%)
8.1.4. Segmentation (USD Billion), 2024-2030, By
8.1.4.1. Product Type, Value (USD Billion), Volume (Thousand Units)
8.1.4.1.1. Drug Delivery Systems
8.1.4.1.1.1. Inhalers
8.1.4.1.1.2. Nebulizers
8.1.4.1.1.3. Insulin Pumps
8.1.4.1.1.4. Chemotherapy Pumps
8.1.4.1.1.5. Pain Management Pumps
8.1.4.1.1.6. Pen Injectors
8.1.4.1.1.7. Syringes
8.1.4.1.1.8. Auto-Injectors
8.1.4.1.1.9. Transdermal Patches
8.1.4.1.1.10. Others
8.1.4.1.2. Medical Devices
8.1.4.1.2.1. Pacemakers
8.1.4.1.2.2. Cochlear Implants
8.1.4.1.2.3. Orthopedic Implants
8.1.4.1.2.4. Glucose Monitors
8.1.4.1.2.5. Pluse Oximeters
8.1.4.1.2.6. Blood Pressure Monitors
8.1.4.1.2.7. Dialysis Machines
8.1.4.1.2.8. Respirators
8.1.4.1.2.9. Endoscopes
8.1.4.1.2.9.1. Single Use
8.1.4.1.2.9.2. Reusable
8.1.4.1.2.10. Laparoscopic Instruments
8.1.4.1.2.11. Catheters
8.1.4.1.2.12. Scalpels
8.1.4.1.2.13. Forceps
8.1.4.1.2.14. Retractors
8.1.4.1.2.15. Surgical Sutures
8.1.4.1.2.16. Others
8.1.4.1.3. Diagnostic Devices
8.1.4.1.3.1. X-ray Machines
8.1.4.1.3.2. MRI Scanners
8.1.4.1.3.3. CT Scanners
8.1.4.1.3.4. Ultrasound Systems
8.1.4.1.3.5. Blood Glucose Meters
8.1.4.1.3.6. Rapid HIV Tests
8.1.4.1.3.7. Blood Gas Analyzers
8.1.4.1.3.8. PCR Machines
8.1.4.1.3.9. Immunoassay Analyzers
8.1.4.1.3.10. Hematology Analyzers
8.1.4.1.3.11. DNA Sequencers
8.1.4.1.3.12. Ophthalmoscopes
8.1.4.1.3.13. ECG Monitors
8.1.4.1.3.14. Holter Monitors
8.1.4.1.3.15. Smartwatches with Health Monitoring Features
8.1.4.1.3.16. Others
8.1.4.2. Raw Material, Value (USD Billion)
8.1.4.2.1. Metal
8.1.4.2.2. Plastic
8.1.4.2.2.1. General-Purpose Engineering Plastics
8.1.4.2.2.2. Super Engineering Plastics
8.1.4.2.3. Ceramics
8.1.4.2.4. Others
8.1.4.3. End User, Value (USD Billion)
8.1.4.3.1. Hospitals
8.1.4.3.2. Clinics
8.1.4.3.3. Diagnostic Centers
8.1.4.3.4. Ambulatory Surgical Centers (ASCs)
8.1.4.3.5. Research Laboratories
8.1.4.3.6. Home Healthcare
8.1.4.4. Country Level Analysis
8.1.4.4.1. China
8.1.4.4.2. Japan
8.1.4.4.3. India
8.1.4.4.4. Australia
8.1.4.4.5. South Korea
8.1.4.4.6. Vietnam
8.1.4.4.7. Thailand
8.1.4.4.8. Singapore
8.1.4.4.9. Malaysia
8.1.4.4.10. Rest of Asia Pacific
9. Latin America Market
9.1. Overview
9.1.1. Market Value (USD Billion), Volume (Thousand Units), Current and Future Projections, 2024-2030
9.1.2. Increment $ Opportunity Assessment, 2024-2030
9.1.3. Year-on-Year Growth Forecast (%)
9.1.4. Segmentation (USD Billion), 2024-2030, By
9.1.4.1. Product Type, Value (USD Billion), Volume (Thousand Units)
9.1.4.1.1. Drug Delivery Systems
9.1.4.1.1.1. Inhalers
9.1.4.1.1.2. Nebulizers
9.1.4.1.1.3. Insulin Pumps
9.1.4.1.1.4. Chemotherapy Pumps
9.1.4.1.1.5. Pain Management Pumps
9.1.4.1.1.6. Pen Injectors
9.1.4.1.1.7. Syringes
9.1.4.1.1.8. Auto-Injectors
9.1.4.1.1.9. Transdermal Patches
9.1.4.1.1.10. Others
9.1.4.1.2. Medical Devices
9.1.4.1.2.1. Pacemakers
9.1.4.1.2.2. Cochlear Implants
9.1.4.1.2.3. Orthopedic Implants
9.1.4.1.2.4. Glucose Monitors
9.1.4.1.2.5. Pluse Oximeters
9.1.4.1.2.6. Blood Pressure Monitors
9.1.4.1.2.7. Dialysis Machines
9.1.4.1.2.8. Respirators
9.1.4.1.2.9. Endoscopes
9.1.4.1.2.9.1. Single Use
9.1.4.1.2.9.2. Reusable
9.1.4.1.2.10. Laparoscopic Instruments
9.1.4.1.2.11. Catheters
9.1.4.1.2.12. Scalpels
9.1.4.1.2.13. Forceps
9.1.4.1.2.14. Retractors
9.1.4.1.2.15. Surgical Sutures
9.1.4.1.2.16. Others
9.1.4.1.3. Diagnostic Devices
9.1.4.1.3.1. X-ray Machines
9.1.4.1.3.2. MRI Scanners
9.1.4.1.3.3. CT Scanners
9.1.4.1.3.4. Ultrasound Systems
9.1.4.1.3.5. Blood Glucose Meters
9.1.4.1.3.6. Rapid HIV Tests
9.1.4.1.3.7. Blood Gas Analyzers
9.1.4.1.3.8. PCR Machines
9.1.4.1.3.9. Immunoassay Analyzers
9.1.4.1.3.10. Hematology Analyzers
9.1.4.1.3.11. DNA Sequencers
9.1.4.1.3.12. Ophthalmoscopes
9.1.4.1.3.13. ECG Monitors
9.1.4.1.3.14. Holter Monitors
9.1.4.1.3.15. Smartwatches with Health Monitoring Features
9.1.4.1.3.16. Others
9.1.4.2. Raw Material, Value (USD Billion)
9.1.4.2.1. Metal
9.1.4.2.2. Plastic
9.1.4.2.2.1. General-Purpose Engineering Plastics
9.1.4.2.2.2. Super Engineering Plastics
9.1.4.2.3. Ceramics
9.1.4.2.4. Others
9.1.4.3. End User, Value (USD Billion)
9.1.4.3.1. Hospitals
9.1.4.3.2. Clinics
9.1.4.3.3. Diagnostic Centers
9.1.4.3.4. Ambulatory Surgical Centers (ASCs)
9.1.4.3.5. Research Laboratories
9.1.4.3.6. Home Healthcare
9.1.4.4. Country Level Analysis
9.1.4.4.1. Brazil
9.1.4.4.2. Argentina
9.1.4.4.3. Mexico
9.1.4.4.4. Rest of Latin America
9.1.1. Market Value (USD Billion), Volume (Thousand Units), Current and Future Projections, 2024-2030
9.1.2. Increment $ Opportunity Assessment, 2024-2030
9.1.3. Year-on-Year Growth Forecast (%)
9.1.4. Segmentation (USD Billion), 2024-2030, By
9.1.4.1. Product Type, Value (USD Billion), Volume (Thousand Units)
9.1.4.1.1. Drug Delivery Systems
9.1.4.1.1.1. Inhalers
9.1.4.1.1.2. Nebulizers
9.1.4.1.1.3. Insulin Pumps
9.1.4.1.1.4. Chemotherapy Pumps
9.1.4.1.1.5. Pain Management Pumps
9.1.4.1.1.6. Pen Injectors
9.1.4.1.1.7. Syringes
9.1.4.1.1.8. Auto-Injectors
9.1.4.1.1.9. Transdermal Patches
9.1.4.1.1.10. Others
9.1.4.1.2. Medical Devices
9.1.4.1.2.1. Pacemakers
9.1.4.1.2.2. Cochlear Implants
9.1.4.1.2.3. Orthopedic Implants
9.1.4.1.2.4. Glucose Monitors
9.1.4.1.2.5. Pluse Oximeters
9.1.4.1.2.6. Blood Pressure Monitors
9.1.4.1.2.7. Dialysis Machines
9.1.4.1.2.8. Respirators
9.1.4.1.2.9. Endoscopes
9.1.4.1.2.9.1. Single Use
9.1.4.1.2.9.2. Reusable
9.1.4.1.2.10. Laparoscopic Instruments
9.1.4.1.2.11. Catheters
9.1.4.1.2.12. Scalpels
9.1.4.1.2.13. Forceps
9.1.4.1.2.14. Retractors
9.1.4.1.2.15. Surgical Sutures
9.1.4.1.2.16. Others
9.1.4.1.3. Diagnostic Devices
9.1.4.1.3.1. X-ray Machines
9.1.4.1.3.2. MRI Scanners
9.1.4.1.3.3. CT Scanners
9.1.4.1.3.4. Ultrasound Systems
9.1.4.1.3.5. Blood Glucose Meters
9.1.4.1.3.6. Rapid HIV Tests
9.1.4.1.3.7. Blood Gas Analyzers
9.1.4.1.3.8. PCR Machines
9.1.4.1.3.9. Immunoassay Analyzers
9.1.4.1.3.10. Hematology Analyzers
9.1.4.1.3.11. DNA Sequencers
9.1.4.1.3.12. Ophthalmoscopes
9.1.4.1.3.13. ECG Monitors
9.1.4.1.3.14. Holter Monitors
9.1.4.1.3.15. Smartwatches with Health Monitoring Features
9.1.4.1.3.16. Others
9.1.4.2. Raw Material, Value (USD Billion)
9.1.4.2.1. Metal
9.1.4.2.2. Plastic
9.1.4.2.2.1. General-Purpose Engineering Plastics
9.1.4.2.2.2. Super Engineering Plastics
9.1.4.2.3. Ceramics
9.1.4.2.4. Others
9.1.4.3. End User, Value (USD Billion)
9.1.4.3.1. Hospitals
9.1.4.3.2. Clinics
9.1.4.3.3. Diagnostic Centers
9.1.4.3.4. Ambulatory Surgical Centers (ASCs)
9.1.4.3.5. Research Laboratories
9.1.4.3.6. Home Healthcare
9.1.4.4. Country Level Analysis
9.1.4.4.1. Brazil
9.1.4.4.2. Argentina
9.1.4.4.3. Mexico
9.1.4.4.4. Rest of Latin America
10. Middle East & Africa Market
10.1. Overview
10.1.1. Market Value (USD Billion), Volume (Thousand Units), Current and Future Projections, 2024-2030
10.1.2. Increment $ Opportunity Assessment, 2024-2030
10.1.3. Year-on-Year Growth Forecast (%)
10.1.4. Segmentation (USD Billion), 2024-2030, By
10.1.4.1. Product Type, Value (USD Billion), Volume (Thousand Units)
10.1.4.1.1. Drug Delivery Systems
10.1.4.1.1.1. Inhalers
10.1.4.1.1.2. Nebulizers
10.1.4.1.1.3. Insulin Pumps
10.1.4.1.1.4. Chemotherapy Pumps
10.1.4.1.1.5. Pain Management Pumps
10.1.4.1.1.6. Pen Injectors
10.1.4.1.1.7. Syringes
10.1.4.1.1.8. Auto-Injectors
10.1.4.1.1.9. Transdermal Patches
10.1.4.1.1.10. Others
10.1.4.1.2. Medical Devices
10.1.4.1.2.1. Pacemakers
10.1.4.1.2.2. Cochlear Implants
10.1.4.1.2.3. Orthopedic Implants
10.1.4.1.2.4. Glucose Monitors
10.1.4.1.2.5. Pluse Oximeters
10.1.4.1.2.6. Blood Pressure Monitors
10.1.4.1.2.7. Dialysis Machines
10.1.4.1.2.8. Respirators
10.1.4.1.2.9. Endoscopes
10.1.4.1.2.9.1. Single Use
10.1.4.1.2.9.2. Reusable
10.1.4.1.2.10. Laparoscopic Instruments
10.1.4.1.2.11. Catheters
10.1.4.1.2.12. Scalpels
10.1.4.1.2.13. Forceps
10.1.4.1.2.14. Retractors
10.1.4.1.2.15. Surgical Sutures
10.1.4.1.2.16. Others
10.1.4.1.3. Diagnostic Devices
10.1.4.1.3.1. X-ray Machines
10.1.4.1.3.2. MRI Scanners
10.1.4.1.3.3. CT Scanners
10.1.4.1.3.4. Ultrasound Systems
10.1.4.1.3.5. Blood Glucose Meters
10.1.4.1.3.6. Rapid HIV Tests
10.1.4.1.3.7. Blood Gas Analyzers
10.1.4.1.3.8. PCR Machines
10.1.4.1.3.9. Immunoassay Analyzers
10.1.4.1.3.10. Hematology Analyzers
10.1.4.1.3.11. DNA Sequencers
10.1.4.1.3.12. Ophthalmoscopes
10.1.4.1.3.13. ECG Monitors
10.1.4.1.3.14. Holter Monitors
10.1.4.1.3.15. Smartwatches with Health Monitoring Features
10.1.4.1.3.16. Others
10.1.4.2. Raw Material, Value (USD Billion)
10.1.4.2.1. Metal
10.1.4.2.2. Plastic
10.1.4.2.2.1. General-Purpose Engineering Plastics
10.1.4.2.2.2. Super Engineering Plastics
10.1.4.2.3. Ceramics
10.1.4.2.4. Others
10.1.4.3. End User, Value (USD Billion)
10.1.4.3.1. Hospitals
10.1.4.3.2. Clinics
10.1.4.3.3. Diagnostic Centers
10.1.4.3.4. Ambulatory Surgical Centers (ASCs)
10.1.4.3.5. Research Laboratories
10.1.4.3.6. Home Healthcare
10.1.4.4. Country Level Analysis
10.1.4.4.1. GCC
10.1.4.4.2. Israel
10.1.4.4.3. South Africa
10.1.4.4.4. Rest of Middle East & Africa
10.1.1. Market Value (USD Billion), Volume (Thousand Units), Current and Future Projections, 2024-2030
10.1.2. Increment $ Opportunity Assessment, 2024-2030
10.1.3. Year-on-Year Growth Forecast (%)
10.1.4. Segmentation (USD Billion), 2024-2030, By
10.1.4.1. Product Type, Value (USD Billion), Volume (Thousand Units)
10.1.4.1.1. Drug Delivery Systems
10.1.4.1.1.1. Inhalers
10.1.4.1.1.2. Nebulizers
10.1.4.1.1.3. Insulin Pumps
10.1.4.1.1.4. Chemotherapy Pumps
10.1.4.1.1.5. Pain Management Pumps
10.1.4.1.1.6. Pen Injectors
10.1.4.1.1.7. Syringes
10.1.4.1.1.8. Auto-Injectors
10.1.4.1.1.9. Transdermal Patches
10.1.4.1.1.10. Others
10.1.4.1.2. Medical Devices
10.1.4.1.2.1. Pacemakers
10.1.4.1.2.2. Cochlear Implants
10.1.4.1.2.3. Orthopedic Implants
10.1.4.1.2.4. Glucose Monitors
10.1.4.1.2.5. Pluse Oximeters
10.1.4.1.2.6. Blood Pressure Monitors
10.1.4.1.2.7. Dialysis Machines
10.1.4.1.2.8. Respirators
10.1.4.1.2.9. Endoscopes
10.1.4.1.2.9.1. Single Use
10.1.4.1.2.9.2. Reusable
10.1.4.1.2.10. Laparoscopic Instruments
10.1.4.1.2.11. Catheters
10.1.4.1.2.12. Scalpels
10.1.4.1.2.13. Forceps
10.1.4.1.2.14. Retractors
10.1.4.1.2.15. Surgical Sutures
10.1.4.1.2.16. Others
10.1.4.1.3. Diagnostic Devices
10.1.4.1.3.1. X-ray Machines
10.1.4.1.3.2. MRI Scanners
10.1.4.1.3.3. CT Scanners
10.1.4.1.3.4. Ultrasound Systems
10.1.4.1.3.5. Blood Glucose Meters
10.1.4.1.3.6. Rapid HIV Tests
10.1.4.1.3.7. Blood Gas Analyzers
10.1.4.1.3.8. PCR Machines
10.1.4.1.3.9. Immunoassay Analyzers
10.1.4.1.3.10. Hematology Analyzers
10.1.4.1.3.11. DNA Sequencers
10.1.4.1.3.12. Ophthalmoscopes
10.1.4.1.3.13. ECG Monitors
10.1.4.1.3.14. Holter Monitors
10.1.4.1.3.15. Smartwatches with Health Monitoring Features
10.1.4.1.3.16. Others
10.1.4.2. Raw Material, Value (USD Billion)
10.1.4.2.1. Metal
10.1.4.2.2. Plastic
10.1.4.2.2.1. General-Purpose Engineering Plastics
10.1.4.2.2.2. Super Engineering Plastics
10.1.4.2.3. Ceramics
10.1.4.2.4. Others
10.1.4.3. End User, Value (USD Billion)
10.1.4.3.1. Hospitals
10.1.4.3.2. Clinics
10.1.4.3.3. Diagnostic Centers
10.1.4.3.4. Ambulatory Surgical Centers (ASCs)
10.1.4.3.5. Research Laboratories
10.1.4.3.6. Home Healthcare
10.1.4.4. Country Level Analysis
10.1.4.4.1. GCC
10.1.4.4.2. Israel
10.1.4.4.3. South Africa
10.1.4.4.4. Rest of Middle East & Africa
11. Global Economic Scenario
11.1. World Economic Outlook
12. About the Publisher
12.1. Global Clientele
Companies Mentioned
- Abbott Laboratories
- Boston Dynamics
- Roche Diagnostics
- Siemens Healthineers AG
